Spezialisierte Zutat

β-NAD+ Manufacturer & Bulk NAD+ Powder Supplier

β-Nicotinamide Adenine Dinucleotide (β-NAD), CAS No. 53-84-9, is supplied as a white powder soluble in water, with batch-specific HPLC results and analytical specifications available for review.

β-NAD+ Powder Product image area

β-Nicotinamide Adenine Dinucleotide

β-Nicotinamide Adenine Dinucleotide (β-NAD)

Produktname β-Nicotinamide Adenine Dinucleotide
CAS-Nr. 53-84-9
Molekulare Formel C₂₁H₂₇N₇O₁₄P₂
Molekulargewicht 663,43 g/mol

Direct β-NAD+

Direct β-NAD+ for Formulation Development

For formulation teams evaluating direct NAD+ materials, the important questions are the material identity, analytical basis, physical characteristics and fit with the intended process. β-NAD+ provides a defined direct NAD+ material for that evaluation.

Direct NAD+ Form

β-NAD+ is nicotinamide adenine dinucleotide in its oxidized form. It is chemically distinct from precursor ingredients such as NMN and NR, and from NADH, the reduced form of the dinucleotide.

Material β-Nicotinamide Adenine Dinucleotide Chemische Form Oxidized NAD

Powder Characteristics

The material is supplied as a white powder and is soluble in water. These characteristics can be considered together with the dosage form, processing conditions, water exposure and finished-product stability requirements.

Erscheinungsbild White powder Löslichkeit Wasserlöslich

Batch Information

β-NAD+ Batch Information

Produkt β-Nicotinamide Adenine Dinucleotide
Batch No. EF251225002
Manufacture Date 2025.12.25
Test Date 2026.01.05
Expiry Date 2027.12.24

Standard: Enterprise standards.

Technical Data

β-NAD+ Powder Specification & COA

Test Item Spezifikation Test Method Result
Physical & Chemical Properties
Erscheinungsbild Weißes bis cremefarbenes Pulver Visual inspection White powder
Löslichkeit Wasserlöslich Visual inspection Wasserlöslich
Reinheit ≥99.0% HPLC 99.68%
Assay (dry basis) 98.0%–102.0% HPLC 99.57%
Water content ≤8,01 TP3T Verlust beim Trocknen 6.39%
Schwermetalle
Pb ≤0.5 ppm GB 5009.12 N.D.
As ≤0.5 ppm GB 5009.11 Conform
Hg ≤0.5 ppm GB 5009.17 N.D.
Cd ≤0.5 ppm GB 5009.15 N.D.
Microbiological Controls
Total microbial count <300 CFU/g GB 4789.2 Conform
E. coli Nicht erkannt GB 4789.38 N.D.
Yeast and mold <10 CFU/g GB 4789.15 Conform
Salmonellen Nicht erkannt GB 4789.4 N.D.
Staphylococcus aureus Nicht erkannt GB 4789.10 N.D.
COA conclusion: Conformable to all the requested specification.

Application Formats

β-NAD+ Powder for Supplement Formats

The powder can be evaluated in finished products according to the formulation, manufacturing process and applicable product requirements.

01

Kapseln

For capsule formulas where β-NAD+ is part of the specified ingredient composition.

02

Tabletten

For tablet formulations subject to the finished product's composition and process requirements.

03

Sachets & Powder Blends

For dry formats where the ingredient specification and handling requirements are defined.

04

Getränkepulver

For powder-based formulations where the ingredient specification and finished-product requirements are compatible.

Handling & Storage

β-NAD+ Transport and Storage

Transport

Keep sealed, dry and away from light for transportation under room temperature conditions.

Room temperature

Long-Term Storage

Keep sealed and dry for long-term storage.

2°C–8°C
β-NAD+ Ingredient Inquiry

Request β-NAD+ Pricing & Product Information

Share your required quantity, application and destination so we can review the material requirements and prepare a quotation.

Spezifikation COA Verpackung Angebot

Senden Sie Ihre Anfrage

    Nach oben blättern